Visit website

BioPharma-Reporter.com

BioPharmaReporter.com provides authoritative, independent and innovative online news coverage of the biopharmaceutical industry. Across written, visual and audio formats it covers the key trends, challenges and dynamics specific to the biopharmaceutical world.

  • Unique coverage of and exclusive insight into core topics.
  • The latest technological breakthroughs in upstream and downstream processing.
  • Bio developments and technologies.

Key Contacts

Melissa Fassbender Editor Tel: +1312 2848590 Email: 

Latest industry news from BioPharma-Reporter.com

More news

14.06.2019

Hired and Retired: The knock-on effect

BMSâ capture of Celgene caught much attention, due to the size and scale of the acqusition, but rival companies have taken the chance to snap up employees that have left after the deal.

13.06.2019

GSK backs up genomics refocus with UCB partnership

GSK signs partnership deal with the University of California to advance genomic research, which sees the creation of a lab and funding for five years of research.

13.06.2019

Bluebird chooses partner for manufacture of its first approved product

Apceth announces that it will be responsible for the commercial manufacture of Zyntelgo, after its approval last week.

12.06.2019

Janssen and Genmab hope for repeat success with next-gen agreement

Genmab agrees deal with Janssen to develop a next-generation mAb product in oncology, which looks to build on the commercial success of the companiesâ partnership on Darzalex.

12.06.2019

Vertex strikes two deals to double down on gene therapy

Vertex agrees to acquire Exonics and to expand its collaboration with CRISPR Therapeutics, which sees it invest $420m in upfront payments to develop its position in gene therapy.

11.06.2019

CAR-Ts that grow on trees: Automating cell therapy manufacturing

As the cell and gene therapies market evolves, pharmaceutical companies aim to adapt to the rising demands and serve larger patient populations.

11.06.2019

Single-use bioprocessing set to grow by 14% through to 2024

The global single-use bioprocessing market is projected to grow to be worth $7bn by 2024, according to a recent report.

11.06.2019

Fujifilm in $10m investment for continuous bioprocessing facility

Utilising single-use flow paths, Fujifilm will create a continuous bioprocessing manufacturing facility after three years of in-house development.

11.06.2019

WuXi ploughs ahead with ‘world’s largest’ single-use facility

WuXi Biologics has selected its construction partner, Jacobs, for the building stage of its âFactory of the Futureâ facility in Dundalk, Ireland.

11.06.2019

Single-use tech ‘reshaping’ the industry as Thermo Fisher further invests

Thermo Fisher invests into bioproduction capabilities as âsingle use continues to reshape the face of the industry,â says single-use technology executive.

Related Brands

Back to brands